Splenda causes weight gain, impairs digestion, and affects chemotherapy & other drugs

More:

As of 2006, only six human trials have been published on Splenda. Of these six trials, only two of the trials were completed and published before the FDA approved sucralose for human consumption, and the two published trials had a grand total of 36 total human subjects.

36 people sure doesn’t sound like many, but wait, it gets worse: only 23 total were actually given sucralose for testing, and here is the real kicker — The longest trial at this time had lasted only four days, and looked at sucralose in relation to tooth decay, not human tolerance.

Even more shocking, the absorption of Splenda into the human body was studied on a grand total of six men! Based on that one human study, the FDA allowed the findings to be generalized as being representative of the entire human population. Including women, children, the elderly, and those with any chronic illness — none of whom were ever examined.

clipped from www.impactlab.com In animals examined for the study, Splenda reduced the amount of good bacteria in the intestines by 50 percent, increased the pH level in the intestines, contributed to increases in body weight and affected P-glycoprotein (P-gp) levels in such a way that crucial health-related drugs could be rejected. The P-gp effect could result in medications used in chemotherapy, AIDS treatment and treatments for heart conditions being shunted back into the intestines, rather than being absorbed by the body. It’s very important to realize that Splenda (sucralose) is actually NOT sugar, despite its marketing slogan “Made from sugar, so it tastes like sugar”. Rather it’s a chlorinated artificial sweetener in line with aspartame and saccharin, and with detrimental health effects to match. They also found unmistakable evidence that Splenda is absorbed by fat, contrary to previous claims. published in the Journal of Toxicology and Environmental Health Splenda Has NEVER Been Proven Safe for Human Consumption